| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/06/2009 | WO2009095445A1 New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate |
| 08/06/2009 | WO2009095437A1 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 08/06/2009 | WO2009095418A1 Use of ulipristal for treating uterine fibroids |
| 08/06/2009 | WO2008116890A3 Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders |
| 08/06/2009 | US20090197946 Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases |
| 08/06/2009 | US20090197899 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use |
| 08/06/2009 | US20090197878 SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR |
| 08/06/2009 | US20090197843 Treatment of Prevention of Unscheduled Bleeding in Women on Progestogen Containing Medication |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | CA2712856A1 Use of eicosapentaenoic acid and/or docosahexaenoic acid in women with endometriosis |
| 08/05/2009 | EP2084124A1 Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| 08/05/2009 | EP2083827A1 Use of estradiol valerate or 17 -estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | CN101501031A Oxazolidone derivatives as pr modulators |
| 08/05/2009 | CN101500585A Fertility agent |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500550A Compositions with enhanced elasticizing activity |
| 08/05/2009 | CN101497881A Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant |
| 08/05/2009 | CN101496891A Chinese medicine for treating qi stagnation type breast hyperplasia and preparation method thereof |
| 08/05/2009 | CN101496883A Chinese medicine preparation for treating lobular hyperplasia of mammary gland |
| 08/05/2009 | CN101496882A Washing lotion for private parts of human body and preparation method thereof |
| 08/05/2009 | CN101496868A Medicament composition |
| 08/05/2009 | CN101496867A Chinese medicine for menopause and preparation method thereof |
| 08/05/2009 | CN101496862A Chinese medicinal composition for treating infertility and preparation method thereof |
| 08/05/2009 | CN101496832A Externally-applied medicament for treating cervical erosion and preparation method thereof |
| 08/05/2009 | CN101496826A Medicament for stretching channel, activating collaterals, compensating deficiency and invigorating yang |
| 08/05/2009 | CN101496821A Lactobacillus effervescent tablet and preparation method thereof |
| 08/05/2009 | CN100523803C Method for detecting active ingredient of Rukuaixiao Chewing tablet |
| 08/05/2009 | CN100522994C Discrimination between GnRH-I and GnRH-II |
| 08/05/2009 | CN100522984C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522960C Thioamide derivatives as progesterone receptor modulators |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522239C Pharmaceutical formulations for sustained drug delivery |
| 08/05/2009 | CN100522238C Pain-relieving and abdominal mass-eliminatnig bolus and its preparation |
| 08/05/2009 | CN100522232C Pharmaceutical composition and usage |
| 08/05/2009 | CN100522220C Oral medicine for treating breast cancer |
| 08/05/2009 | CN100522190C Method for extracting total saponin for Chinese herb medicine clinopodium polycephalum |
| 08/05/2009 | CN100522178C Formulations useful in the treatment of male and female impotence |
| 08/05/2009 | CN100522176C Medicine composition for treating vaginal diseases |
| 08/05/2009 | CN100522143C Gynaecologic leucorrhea removing granules preparation and preparing process thereof |
| 08/05/2009 | CN100521969C Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone |
| 08/04/2009 | US7569564 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 08/04/2009 | US7569557 Compositions of estrogen-cyclodextrin complexes |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569225 Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 08/04/2009 | CA2653189A1 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2420348C Non-hormonal vaginal contraceptive |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192130 Method for Treating Uterine Fibroids |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/29/2009 | CN100518729C Liquor for increasing cow born ratio and its manufacturing method |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/23/2009 | WO2009091332A1 Methods for in vitro maturation of ovarian follicles |
| 07/23/2009 | WO2009090202A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist |
| 07/23/2009 | WO2009048595A9 Herbal combination omega oil aphrodisiac |
| 07/23/2009 | WO2008087421A3 Male contraceptive |
| 07/23/2009 | US20090186896 PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders |
| 07/23/2009 | US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists |
| 07/23/2009 | DE102008005498A1 Adherent, sperm blocking drug combination with contraceptive effect, useful as contraceptive, comprises deionized water, polysaccharide-gum, and alcohol as lubricant, where composition has specific total viscosity |
| 07/23/2009 | CA2711646A1 Methods for in vitro maturation of ovarian follicles |
| 07/23/2009 | CA2618380A1 Feed additive and uses thereof |
| 07/22/2009 | EP2079477A2 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 07/22/2009 | EP2079461A1 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| 07/22/2009 | EP1978981B1 Compositions for vaginal use |
| 07/22/2009 | EP1499290B1 Warming and nonirritating lubricant compositions |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392680B1 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 07/22/2009 | EP1392337B2 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100515478C Chinese medicine composition for treating menstrual period syndrome |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | CA2474698C Polymer-based compositions for sustained release |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |